22 February 2021 : Clinical Research
Fractional Exhaled Nitric Oxide (FeNO) Integrating Airway Hyperresponsiveness (AHR) Examination Promotes Etiologic Diagnosis and Treatment for Children with Chronic Cough
Haiyan Zhu1BCDEF, Chuangli Hao2BCDE, Xingmei Yu2BCDF, Rongrong Zhang1BCD, Wendi Zhou1BCF, Xingzhen Sun1BCF, Yufang Yuan1BCF, Zhaofang Tian1ABDEG*DOI: 10.12659/MSM.928502
Med Sci Monit 2021; 27:e928502
Figure 2 Comparison of baseline fractional exhaled nitric oxide (FeNO) (parts per billion, [ppb]) between children with cough relief and those without cough relief at 4 weeks after the anti-inflammatory treatment. * P<0.05 vs no-relief group.